autoimmune disease Archive — Page 1 of 2

(iStock)
November 11, 2026

Randomized trial: Autoimmune risk score plus fast-track referral speeds diagnosis

There has been no evidence-based guidance for deciding which patients with a positive antinuclear antibody test — a potential indicator of autoimmune disease — need prompt rheumatology referral.

Three colleagues pose together in a laboratory workspace, with shelves of boxes and supplies behind them.
October 5, 2026

Vanderbilt Health to lead national consortium on life-threatening drug reactions of the skin

“For too long, patients who survive these reactions have been left without clear answers about why it happened, which medicines are safe, and what the future holds,” said Elizabeth Phillips, MD, who is leading the consortium.

Three people stand in the Vanderbilt Clinical Research Center beside a wall sign reading “Clinical Research Center.”
April 20, 2026

Drug lifts ‘brain fog’ from lupus patients: Clinical trial

An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. The EG501 study was the inaugural project of Vanderbilt Health’s Drug Repurposing program.

Laboratory team members work and discuss results among computer workstations in a brightly lit clinical testing lab; a sign labeled “Hematology” hangs overhead.
July 1, 2025

New lab for transplant, other specialized testing launches at Vanderbilt Medical Laboratories

The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume.

Jeffrey Rathmell, PhD, left, and Kelsey Voss, PhD, led a multidisciplinary team that identified iron metabolism in T cells as a potential target for treating lupus.
January 13, 2023

Study identifies potential new approach for treating lupus

A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.

(iStock)
October 6, 2022

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.